Clinical Trial Update: The Efficacy of Intravenous Amino Acids in Reducing the Occurrence of AKI After Live Donor Liver Transplant [NA]

View source ↗

Summary

This clinical trial investigates whether intravenous amino acids can reduce acute kidney injury after a live donor liver transplant, and the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Liver Failure

Drugs mentioned

• Intravenous amino acids (amino acids)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Liver Transplant; Complications, AKI - Acute Kidney Injury | NA | Status: NOT_YET_RECRUITING